About CARE™

The CARE™ (Community. Academic. Research. Education.) Faculty is a national group of specialists from across Canada.

We develop education initiatives directed at our peers, as well as to nurses, pharmacists, patients, government and payers. CARE™ programs have been successfully run in oncology, hematology, gastroenterology, infectious disease, neuromuscular, pathology and respirology.


Our Current Events

Recent Publications


This CARE™ prostate cancer section of the CARE™ Perspectives from ASCO 2019 Report features select prostate cancer highlights from content presented at the 2019 ASCO Annual Meeting (abridged section).

View Publication

This issue of CARE™ Perspectives from AAN provides updates on key news along with insights from a recent CARE™ Needs Assessment on MG.

View Publication


CARE™ Perspectives:

AAN 2019 Report


CARE™ Perspectives:

ASCO 2019: RCC & UC Section

This section of the CARE™ Perspectives: ASCO 2019 report summarizes news and updates in renal cell carcinoma (RCC) and urothelial carcinoma (UC).

View Publication

This issue of CARE™ Perspectives from DDW 2019 provides coverage on GI disorders, as well as information regarding a CARE™ Needs Assessment on IBD.

View Publication


CARE™ Perspectives:

DDW 2019 Report


CARE™ Perspectives: ASCO 2019 - Lung Cancer section is now available for download! This report was created in collaboration with CARE™ Oncology faculty members Dr. Barb Melosky and @NormandBlais with additional review from Dr. Randeep Sangha. https://t.co/5CVavR20A9

Pneumonia patients get too many antibiotics -- especially as they leave the hospital. Rea more about it here: https://t.co/C8LU4agsAA

Load More...


November 14, 2018 in News, Oncology

ESMO 2018: News in Oncology – Ovarian Cancer

LBA36 - Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase 2 KEYNOTE-100 study Speaker:…
Read More
November 14, 2018 in Breast Cancer, Medical Oncology, News, Oncology

ESMO 2018: News in Oncology – Metastatic Breast Cancer

290O - Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib + fulvestrant: results from MONALEESA-3 Speaker: Peter A. Fasching (Erlangen, DE) In the MONALEESA-3 trial (NCT02422615), ribociclib…
Read More